As these findings could be reversed with the restoration of mitfa's activity, this work substantiates the notion that mitfa is a modifier of BRAF-driven melanoma and provides a functional link between low MITF expression in patients with their poor melanoma prognosis. Here, BRAF is linked to melanoma.